Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,Leiomyoma of uterus,A1BG,Alpha-1B-glycoprotein,23380,507,0.56 [0.35-0.89],0.0140714342499831
Chapter II Neoplasms,Leiomyoma of uterus,ABCA2,ATP-binding cassette sub-family A member 2,22605,487,1.31 [1.05-1.62],0.0157665131353259
Chapter II Neoplasms,Leiomyoma of uterus,ACAN,Aggrecan core protein,26554,591,0.55 [0.42-0.70],3.390092070464058e-06
Chapter II Neoplasms,Leiomyoma of uterus,ACTA2,"Actin, aortic smooth muscle",26286,584,1.27 [1.11-1.46],0.0007142666044951
Chapter II Neoplasms,Leiomyoma of uterus,ACY1,Aminoacylase-1,26791,593,0.84 [0.75-0.95],0.0064414215835285
Chapter II Neoplasms,Leiomyoma of uterus,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,22605,487,0.79 [0.68-0.93],0.0034199128415716
Chapter II Neoplasms,Leiomyoma of uterus,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,22684,489,1.35 [1.18-1.53],8.348750888500703e-06
Chapter II Neoplasms,Leiomyoma of uterus,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,26286,584,1.33 [1.12-1.59],0.0014950874179833
Chapter II Neoplasms,Leiomyoma of uterus,ADGRG1,Adhesion G-protein coupled receptor G1,26676,589,1.24 [1.10-1.40],0.0003535288172709
Chapter II Neoplasms,Leiomyoma of uterus,ADGRG2,Adhesion G-protein coupled receptor G2,26791,593,0.61 [0.47-0.80],0.0003389492574093
Chapter II Neoplasms,Leiomyoma of uterus,ADH1B,All-trans-retinol dehydrogenase,22843,501,0.86 [0.77-0.97],0.0167408155192062
Chapter II Neoplasms,Leiomyoma of uterus,AGXT,Serine--pyruvate aminotransferase,26791,593,0.90 [0.82-0.99],0.038020788995301
Chapter II Neoplasms,Leiomyoma of uterus,AHNAK,Neuroblast differentiation-associated protein AHNAK,22743,496,0.62 [0.47-0.82],0.0009602869860115
Chapter II Neoplasms,Leiomyoma of uterus,AHSP,Alpha-hemoglobin-stabilizing protein,26753,591,0.91 [0.84-0.99],0.0195648642202417
Chapter II Neoplasms,Leiomyoma of uterus,AK1,Adenylate kinase isoenzyme 1,26791,593,0.87 [0.78-0.98],0.0178143661515872
Chapter II Neoplasms,Leiomyoma of uterus,AKAP12,A-kinase anchor protein 12,22843,501,0.65 [0.42-0.99],0.0447063962410225
Chapter II Neoplasms,Leiomyoma of uterus,ALCAM,CD166 antigen,27119,604,0.51 [0.35-0.75],0.0004935646359783
Chapter II Neoplasms,Leiomyoma of uterus,ALDH1A1,Retinal dehydrogenase 1,26793,591,0.81 [0.71-0.93],0.0030796822139208
Chapter II Neoplasms,Leiomyoma of uterus,AMBP,Protein AMBP,26975,597,0.64 [0.45-0.93],0.0176076815376478
Chapter II Neoplasms,Leiomyoma of uterus,ANGPTL3,Angiopoietin-related protein 3,26785,599,0.77 [0.63-0.94],0.0090383595269792
Chapter II Neoplasms,Leiomyoma of uterus,ANKRD54,Ankyrin repeat domain-containing protein 54,26159,574,0.87 [0.76-1.00],0.0489732561326697
Chapter II Neoplasms,Leiomyoma of uterus,ANPEP,Aminopeptidase N,26830,598,0.74 [0.57-0.97],0.0261901899581054
Chapter II Neoplasms,Leiomyoma of uterus,ANXA5,Annexin A5,26044,572,1.27 [1.01-1.60],0.0436214172623096
Chapter II Neoplasms,Leiomyoma of uterus,APLP1,Amyloid-like protein 1,26791,593,0.81 [0.70-0.93],0.0032401366204514
Chapter II Neoplasms,Leiomyoma of uterus,APOA1,Apolipoprotein A-I,23380,507,0.71 [0.50-0.99],0.0413492134536849
Chapter II Neoplasms,Leiomyoma of uterus,APOA4,Apolipoprotein A-IV,23380,507,0.69 [0.54-0.89],0.0041447185572638
Chapter II Neoplasms,Leiomyoma of uterus,APOF,Apolipoprotein F,23354,511,0.77 [0.61-0.98],0.0338211257001321
Chapter II Neoplasms,Leiomyoma of uterus,AREG,Amphiregulin,26676,589,1.36 [1.20-1.53],7.643937550327708e-07
Chapter II Neoplasms,Leiomyoma of uterus,ARG1,Arginase-1,26645,590,0.86 [0.75-0.98],0.0267415956093267
Chapter II Neoplasms,Leiomyoma of uterus,ART3,Ecto-ADP-ribosyltransferase 3,26878,601,0.78 [0.62-0.97],0.0225633174892252
Chapter II Neoplasms,Leiomyoma of uterus,ASAH1,Acid ceramidase,23108,500,0.80 [0.66-0.97],0.021706194111117
Chapter II Neoplasms,Leiomyoma of uterus,ASAH2,Neutral ceramidase,26606,585,1.18 [1.02-1.36],0.0283650570139252
Chapter II Neoplasms,Leiomyoma of uterus,ASRGL1,Isoaspartyl peptidase/L-asparaginase,22743,496,0.91 [0.84-0.99],0.0302422208816396
Chapter II Neoplasms,Leiomyoma of uterus,AXL,Tyrosine-protein kinase receptor UFO,26878,601,0.72 [0.55-0.93],0.0130743108503844
Chapter II Neoplasms,Leiomyoma of uterus,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",22743,496,0.78 [0.62-0.98],0.033738293121206
Chapter II Neoplasms,Leiomyoma of uterus,B4GAT1,"Beta-1,4-glucuronyltransferase 1",26793,591,0.58 [0.43-0.79],0.0003982364195794
Chapter II Neoplasms,Leiomyoma of uterus,BAG6,Large proline-rich protein BAG6,26286,584,0.80 [0.65-0.98],0.0283500799297187
Chapter II Neoplasms,Leiomyoma of uterus,BCAN,Brevican core protein,26606,585,1.32 [1.06-1.64],0.0143170958508052
Chapter II Neoplasms,Leiomyoma of uterus,BCHE,Cholinesterase,22924,500,0.62 [0.48-0.79],0.0001460058547305
Chapter II Neoplasms,Leiomyoma of uterus,BGLAP,Osteocalcin,23332,508,0.89 [0.81-0.97],0.0084941257761613
Chapter II Neoplasms,Leiomyoma of uterus,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,22605,487,1.43 [1.03-1.97],0.0322469534366632
Chapter II Neoplasms,Leiomyoma of uterus,BMP4,Bone morphogenetic protein 4,26566,583,0.81 [0.68-0.95],0.010356249637445
Chapter II Neoplasms,Leiomyoma of uterus,BMP6,Bone morphogenetic protein 6,26242,583,1.44 [1.21-1.72],4.798089215447344e-05
Chapter II Neoplasms,Leiomyoma of uterus,BOC,Brother of CDO,26286,584,1.63 [1.20-2.21],0.0017182398403178
Chapter II Neoplasms,Leiomyoma of uterus,BSG,Basigin,27022,598,0.69 [0.49-0.97],0.0309307532022608
Chapter II Neoplasms,Leiomyoma of uterus,BTN3A2,Butyrophilin subfamily 3 member A2,26749,595,1.23 [1.02-1.49],0.0296651184985177
Chapter II Neoplasms,Leiomyoma of uterus,C1QA,Complement C1q subcomponent subunit A,26928,591,2.04 [1.51-2.77],4.053887112098189e-06
Chapter II Neoplasms,Leiomyoma of uterus,C2,Complement C2,26830,600,0.68 [0.56-0.83],0.0001243094717431
Chapter II Neoplasms,Leiomyoma of uterus,C7,Complement component C7,22821,493,1.47 [1.11-1.94],0.0065855869774193
Chapter II Neoplasms,Leiomyoma of uterus,C8B,Complement component C8 beta chain,23380,507,0.67 [0.51-0.88],0.0036864196141676
Chapter II Neoplasms,Leiomyoma of uterus,CA1,Carbonic anhydrase 1,26170,591,0.85 [0.76-0.95],0.0047448891849211
Chapter II Neoplasms,Leiomyoma of uterus,CA11,Carbonic anhydrase-related protein 11,26159,574,1.24 [1.04-1.49],0.0190271841855931
Chapter II Neoplasms,Leiomyoma of uterus,CA12,Carbonic anhydrase 12,26676,589,1.68 [1.40-2.01],1.5006957500852312e-08
Chapter II Neoplasms,Leiomyoma of uterus,CA2,Carbonic anhydrase 2,26704,588,0.89 [0.80-0.99],0.0256946398919196
Chapter II Neoplasms,Leiomyoma of uterus,CA3,Carbonic anhydrase 3,27072,604,0.83 [0.74-0.93],0.0015275109953216
Chapter II Neoplasms,Leiomyoma of uterus,CA4,Carbonic anhydrase 4,27119,604,0.64 [0.47-0.86],0.0034777960049813
Chapter II Neoplasms,Leiomyoma of uterus,CA6,Carbonic anhydrase 6,26707,585,0.87 [0.78-0.98],0.0183441483757102
Chapter II Neoplasms,Leiomyoma of uterus,CA8,Carbonic anhydrase-related protein,22684,489,0.63 [0.42-0.95],0.0263252165122979
Chapter II Neoplasms,Leiomyoma of uterus,CA9,Carbonic anhydrase 9,27012,597,1.21 [1.04-1.41],0.0154290374107303
Chapter II Neoplasms,Leiomyoma of uterus,CALB1,Calbindin,26676,589,0.84 [0.71-1.00],0.0446180562830127
Chapter II Neoplasms,Leiomyoma of uterus,CAT,Catalase,22988,501,0.82 [0.70-0.96],0.0147586421786782
Chapter II Neoplasms,Leiomyoma of uterus,CCDC80,Coiled-coil domain-containing protein 80,26791,593,1.28 [1.04-1.58],0.0214255591273923
Chapter II Neoplasms,Leiomyoma of uterus,CCL13,C-C motif chemokine 13,27018,596,0.90 [0.81-0.99],0.0382886850024002
Chapter II Neoplasms,Leiomyoma of uterus,CCL18,C-C motif chemokine 18,26397,596,0.84 [0.75-0.94],0.002043626751969
Chapter II Neoplasms,Leiomyoma of uterus,CCL2,C-C motif chemokine 2,26566,583,0.85 [0.74-0.98],0.025129541377376
Chapter II Neoplasms,Leiomyoma of uterus,CCL20,C-C motif chemokine 20,27067,598,0.91 [0.84-1.00],0.0463885747392287
Chapter II Neoplasms,Leiomyoma of uterus,CCL28,C-C motif chemokine 28,26665,594,1.14 [1.02-1.28],0.0210200983243281
Chapter II Neoplasms,Leiomyoma of uterus,CCN4,CCN family member 4,27012,597,1.62 [1.39-1.90],1.4716820310202383e-09
Chapter II Neoplasms,Leiomyoma of uterus,CCN5,CCN family member 5,26793,591,1.22 [1.02-1.46],0.0329154915903433
Chapter II Neoplasms,Leiomyoma of uterus,CD101,Immunoglobulin superfamily member 2,23220,507,0.78 [0.64-0.95],0.0120287960577769
Chapter II Neoplasms,Leiomyoma of uterus,CD14,Monocyte differentiation antigen CD14,26206,588,0.75 [0.63-0.89],0.0011742214229742
Chapter II Neoplasms,Leiomyoma of uterus,CD300LG,CMRF35-like molecule 9,26793,591,0.70 [0.58-0.86],0.0004115257460256
Chapter II Neoplasms,Leiomyoma of uterus,CD34,Hematopoietic progenitor cell antigen CD34,26930,596,0.62 [0.46-0.84],0.0017020134289186
Chapter II Neoplasms,Leiomyoma of uterus,CD36,Platelet glycoprotein 4,22684,489,0.82 [0.68-1.00],0.0492489697341475
Chapter II Neoplasms,Leiomyoma of uterus,CD40,Tumor necrosis factor receptor superfamily member 5,26785,593,0.86 [0.74-0.99],0.0386240590243286
Chapter II Neoplasms,Leiomyoma of uterus,CD46,Membrane cofactor protein,26605,595,0.69 [0.53-0.89],0.0051247652068495
Chapter II Neoplasms,Leiomyoma of uterus,CD59,CD59 glycoprotein,25795,573,0.59 [0.41-0.86],0.0064444496718382
Chapter II Neoplasms,Leiomyoma of uterus,CD6,T-cell differentiation antigen CD6,27022,598,0.84 [0.74-0.96],0.012768168359569
Chapter II Neoplasms,Leiomyoma of uterus,CD8A,T-cell surface glycoprotein CD8 alpha chain,27016,598,0.86 [0.74-0.99],0.0397320745629384
Chapter II Neoplasms,Leiomyoma of uterus,CD93,Complement component C1q receptor,25768,582,0.67 [0.53-0.86],0.0014045052331373
Chapter II Neoplasms,Leiomyoma of uterus,CD99L2,CD99 antigen-like protein 2,26793,591,0.66 [0.48-0.89],0.0069421854234115
Chapter II Neoplasms,Leiomyoma of uterus,CDC123,Cell division cycle protein 123 homolog,22508,482,0.84 [0.72-0.98],0.0240057638591594
Chapter II Neoplasms,Leiomyoma of uterus,CDC25A,M-phase inducer phosphatase 1,22508,482,0.79 [0.63-1.00],0.049664103318999
Chapter II Neoplasms,Leiomyoma of uterus,CDH1,Cadherin-1,25878,575,0.70 [0.57-0.86],0.0007676518503228
Chapter II Neoplasms,Leiomyoma of uterus,CDH15,Cadherin-15,26968,597,0.81 [0.68-0.96],0.01783139845995
Chapter II Neoplasms,Leiomyoma of uterus,CDH17,Cadherin-17,26791,593,0.87 [0.78-0.97],0.0136146968394673
Chapter II Neoplasms,Leiomyoma of uterus,CDH2,Cadherin-2,26791,593,0.78 [0.64-0.95],0.012353305681662
Chapter II Neoplasms,Leiomyoma of uterus,CDH3,Cadherin-3,27016,598,3.13 [2.69-3.65],1.81621176034753e-49
Chapter II Neoplasms,Leiomyoma of uterus,CDH5,Cadherin-5,27119,604,0.68 [0.54-0.87],0.0018203173796286
Chapter II Neoplasms,Leiomyoma of uterus,CDHR2,Cadherin-related family member 2,26676,589,0.85 [0.77-0.93],0.0006069069094579
Chapter II Neoplasms,Leiomyoma of uterus,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,26848,591,0.77 [0.61-0.98],0.0334783763025595
Chapter II Neoplasms,Leiomyoma of uterus,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,23220,507,0.79 [0.72-0.88],7.723326826690698e-06
Chapter II Neoplasms,Leiomyoma of uterus,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,22914,498,0.86 [0.74-0.99],0.036621046874826
Chapter II Neoplasms,Leiomyoma of uterus,CEMIP2,Cell surface hyaluronidase,22684,489,1.27 [1.04-1.55],0.019938400060475
Chapter II Neoplasms,Leiomyoma of uterus,CENPJ,Centromere protein J,22914,498,0.88 [0.77-1.00],0.0483873763612518
Chapter II Neoplasms,Leiomyoma of uterus,CEP290,Centrosomal protein of 290 kDa,22914,498,0.83 [0.69-0.99],0.0423251055301709
Chapter II Neoplasms,Leiomyoma of uterus,CFB,Complement factor B,22931,497,0.76 [0.59-0.97],0.0291333812243162
Chapter II Neoplasms,Leiomyoma of uterus,CFH,Complement factor H,21982,480,0.58 [0.40-0.84],0.0038789615592135
Chapter II Neoplasms,Leiomyoma of uterus,CFHR5,Complement factor H-related protein 5,23041,499,0.81 [0.67-0.98],0.0319451013976534
Chapter II Neoplasms,Leiomyoma of uterus,CFI,Complement factor I,23380,507,0.50 [0.33-0.75],0.0008907294912021
Chapter II Neoplasms,Leiomyoma of uterus,CFP,Properdin,23380,507,0.51 [0.34-0.77],0.0012314553876972
Chapter II Neoplasms,Leiomyoma of uterus,CGA,Glycoprotein hormones alpha chain,26793,591,0.81 [0.75-0.87],3.8756052285051366e-08
Chapter II Neoplasms,Leiomyoma of uterus,CHAD,Chondroadherin,22843,501,0.76 [0.65-0.89],0.000511788835285
Chapter II Neoplasms,Leiomyoma of uterus,CHGB,Secretogranin-1,26918,595,0.81 [0.68-0.98],0.0271782895513767
Chapter II Neoplasms,Leiomyoma of uterus,CHL1,Neural cell adhesion molecule L1-like protein,26839,600,0.75 [0.60-0.94],0.0136522469047324
Chapter II Neoplasms,Leiomyoma of uterus,CHRDL1,Chordin-like protein 1,26874,594,1.41 [1.11-1.79],0.0044435899108969
Chapter II Neoplasms,Leiomyoma of uterus,CHRDL2,Chordin-like protein 2,26791,593,2.93 [2.64-3.24],6.7828918453046255e-96
Chapter II Neoplasms,Leiomyoma of uterus,CKAP4,Cytoskeleton-associated protein 4,26934,597,1.46 [1.12-1.89],0.0047564024898639
Chapter II Neoplasms,Leiomyoma of uterus,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",26699,592,0.88 [0.80-0.96],0.0050585168055881
Chapter II Neoplasms,Leiomyoma of uterus,CLEC14A,C-type lectin domain family 14 member A,26793,591,0.68 [0.54-0.87],0.0016286193939552
Chapter II Neoplasms,Leiomyoma of uterus,CLEC3B,Tetranectin,22811,497,0.66 [0.44-1.00],0.0480080047468291
Chapter II Neoplasms,Leiomyoma of uterus,CLEC4A,C-type lectin domain family 4 member A,26749,595,0.81 [0.66-0.99],0.0367037102961294
Chapter II Neoplasms,Leiomyoma of uterus,CLGN,Calmegin,22685,498,0.75 [0.61-0.92],0.005837203155398
Chapter II Neoplasms,Leiomyoma of uterus,CLIC5,Chloride intracellular channel protein 5,22685,498,0.68 [0.50-0.92],0.0130941331968632
Chapter II Neoplasms,Leiomyoma of uterus,CNGB3,Cyclic nucleotide-gated cation channel beta-3,22591,487,0.82 [0.68-0.99],0.0380916924985683
Chapter II Neoplasms,Leiomyoma of uterus,CNTN2,Contactin-2,27012,597,0.83 [0.71-0.98],0.0238178806693176
Chapter II Neoplasms,Leiomyoma of uterus,CNTN4,Contactin-4,26793,591,0.74 [0.55-0.99],0.0444154242160374
Chapter II Neoplasms,Leiomyoma of uterus,COCH,Cochlin,23347,511,0.82 [0.68-0.98],0.0293199877291418
Chapter II Neoplasms,Leiomyoma of uterus,COL3A1,Collagen alpha-1(III) chain,23332,508,1.51 [1.06-2.14],0.0219465449485889
Chapter II Neoplasms,Leiomyoma of uterus,COL4A1,Collagen alpha-1(IV) chain,26791,593,1.47 [1.23-1.75],1.6997651040325254e-05
Chapter II Neoplasms,Leiomyoma of uterus,COL5A1,Collagen alpha-1(V) chain,22843,501,1.42 [1.16-1.74],0.0006892968311364
Chapter II Neoplasms,Leiomyoma of uterus,COL6A3,Collagen alpha-3(VI) chain,27119,604,1.52 [1.24-1.87],4.698299897062704e-05
Chapter II Neoplasms,Leiomyoma of uterus,COL9A1,Collagen alpha-1(IX) chain,26749,595,0.79 [0.67-0.93],0.0049604618967432
Chapter II Neoplasms,Leiomyoma of uterus,COMP,Cartilage oligomeric matrix protein,26485,595,0.80 [0.64-0.98],0.0355795824984115
Chapter II Neoplasms,Leiomyoma of uterus,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",22743,496,0.76 [0.61-0.94],0.0127774662332034
Chapter II Neoplasms,Leiomyoma of uterus,CPA2,Carboxypeptidase A2,26919,597,0.84 [0.75-0.95],0.0037377113469492
Chapter II Neoplasms,Leiomyoma of uterus,CPA4,Carboxypeptidase A4,22370,487,1.37 [1.12-1.68],0.0023060428979778
Chapter II Neoplasms,Leiomyoma of uterus,CPB2,Carboxypeptidase B2,23329,506,0.63 [0.43-0.91],0.0147948075789999
Chapter II Neoplasms,Leiomyoma of uterus,CPM,Carboxypeptidase M,26888,593,0.63 [0.52-0.77],6.757543695118716e-06
Chapter II Neoplasms,Leiomyoma of uterus,CRH,Corticoliberin,26114,574,0.87 [0.80-0.95],0.0024337031823617
Chapter II Neoplasms,Leiomyoma of uterus,CRHBP,Corticotropin-releasing factor-binding protein,26790,588,0.54 [0.43-0.69],9.955341201057173e-07
Chapter II Neoplasms,Leiomyoma of uterus,CRLF1,Cytokine receptor-like factor 1,26922,598,2.28 [1.74-2.97],1.6442411801126527e-09
Chapter II Neoplasms,Leiomyoma of uterus,CRTAC1,Cartilage acidic protein 1,27119,604,0.77 [0.61-0.98],0.0326084647124978
Chapter II Neoplasms,Leiomyoma of uterus,CRX,Cone-rod homeobox protein,26286,584,0.92 [0.86-1.00],0.0387644997321111
Chapter II Neoplasms,Leiomyoma of uterus,CSF3,Granulocyte colony-stimulating factor,26247,581,0.85 [0.73-0.99],0.0318435989181162
Chapter II Neoplasms,Leiomyoma of uterus,CSPG4,Chondroitin sulfate proteoglycan 4,23332,508,1.29 [1.00-1.67],0.0473106923322599
Chapter II Neoplasms,Leiomyoma of uterus,CSPG5,Chondroitin sulfate proteoglycan 5,22591,487,1.21 [1.03-1.41],0.0221007018276456
Chapter II Neoplasms,Leiomyoma of uterus,CST3,Cystatin-C,26837,601,0.68 [0.52-0.89],0.0045658323898672
Chapter II Neoplasms,Leiomyoma of uterus,CTNNA1,Catenin alpha-1,22591,487,1.28 [1.05-1.55],0.0122357687471629
Chapter II Neoplasms,Leiomyoma of uterus,CTSD,Cathepsin D,25011,553,0.76 [0.61-0.94],0.0100864885096739
Chapter II Neoplasms,Leiomyoma of uterus,CTSV,Cathepsin L2,26936,596,1.21 [1.04-1.42],0.015892187629365
Chapter II Neoplasms,Leiomyoma of uterus,CXADR,Coxsackievirus and adenovirus receptor,26749,595,0.84 [0.72-0.97],0.019053418559715
Chapter II Neoplasms,Leiomyoma of uterus,CXCL13,C-X-C motif chemokine 13,27016,598,1.16 [1.05-1.27],0.0021542563499941
Chapter II Neoplasms,Leiomyoma of uterus,CXCL16,C-X-C motif chemokine 16,27072,603,0.61 [0.45-0.82],0.0013377023156243
Chapter II Neoplasms,Leiomyoma of uterus,DAAM1,Disheveled-associated activator of morphogenesis 1,22843,501,0.90 [0.81-0.99],0.039853624684097
Chapter II Neoplasms,Leiomyoma of uterus,DCN,Decorin,26286,584,1.54 [1.12-2.12],0.0074605348383232
Chapter II Neoplasms,Leiomyoma of uterus,DCTPP1,dCTP pyrophosphatase 1,26791,593,0.74 [0.59-0.92],0.0073772490840605
Chapter II Neoplasms,Leiomyoma of uterus,DDA1,DET1- and DDB1-associated protein 1,22605,487,1.23 [1.03-1.48],0.0231023099840095
Chapter II Neoplasms,Leiomyoma of uterus,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",26676,589,0.79 [0.67-0.94],0.0076605463958918
Chapter II Neoplasms,Leiomyoma of uterus,DDC,Aromatic-L-amino-acid decarboxylase,26746,592,0.85 [0.73-0.98],0.0288831226224114
Chapter II Neoplasms,Leiomyoma of uterus,DDX39A,ATP-dependent RNA helicase DDX39A,22684,489,0.58 [0.38-0.89],0.0127523241850544
Chapter II Neoplasms,Leiomyoma of uterus,DENND2B,DENN domain-containing protein 2B,22605,487,1.20 [1.05-1.38],0.0094174987054304
Chapter II Neoplasms,Leiomyoma of uterus,DKK3,Dickkopf-related protein 3,27119,604,0.74 [0.58-0.94],0.0152050152106891
Chapter II Neoplasms,Leiomyoma of uterus,DLK1,Protein delta homolog 1,27119,604,0.76 [0.66-0.87],4.3379435425831946e-05
Chapter II Neoplasms,Leiomyoma of uterus,DMD,Dystrophin,22743,496,0.76 [0.63-0.91],0.0033911706306109
Chapter II Neoplasms,Leiomyoma of uterus,DPEP1,Dipeptidase 1,26558,584,0.83 [0.73-0.96],0.0111734868811553
Chapter II Neoplasms,Leiomyoma of uterus,DPP4,Dipeptidyl peptidase 4,26273,589,0.46 [0.36-0.59],3.0431441648532245e-10
Chapter II Neoplasms,Leiomyoma of uterus,DPT,Dermatopontin,27119,604,0.65 [0.50-0.83],0.0007501400814067
Chapter II Neoplasms,Leiomyoma of uterus,DSC2,Desmocollin-2,26511,583,0.76 [0.61-0.94],0.0129261311761882
Chapter II Neoplasms,Leiomyoma of uterus,DSG4,Desmoglein-4,26593,588,0.86 [0.75-0.99],0.0304602211392467
Chapter II Neoplasms,Leiomyoma of uterus,DYNLT1,Dynein light chain Tctex-type 1,22685,498,0.85 [0.76-0.95],0.0054614540375666
Chapter II Neoplasms,Leiomyoma of uterus,EDA2R,Tumor necrosis factor receptor superfamily member 27,27012,597,1.26 [1.03-1.55],0.0252146768979452
Chapter II Neoplasms,Leiomyoma of uterus,EDAR,Tumor necrosis factor receptor superfamily member EDAR,26749,595,0.88 [0.81-0.95],0.00115309960483
Chapter II Neoplasms,Leiomyoma of uterus,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,26831,600,0.78 [0.61-0.99],0.0438497265121329
Chapter II Neoplasms,Leiomyoma of uterus,EGFR,Epidermal growth factor receptor,27119,604,0.53 [0.34-0.82],0.0045776613675299
Chapter II Neoplasms,Leiomyoma of uterus,ENG,Endoglin,27119,604,0.55 [0.36-0.84],0.0059395515974231
Chapter II Neoplasms,Leiomyoma of uterus,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,27119,604,0.59 [0.46-0.76],5.03066758751006e-05
Chapter II Neoplasms,Leiomyoma of uterus,ENTR1,Endosome-associated-trafficking regulator 1,22743,496,0.85 [0.72-0.99],0.0396152899066284
Chapter II Neoplasms,Leiomyoma of uterus,EPCAM,Epithelial cell adhesion molecule,26793,587,0.91 [0.85-0.98],0.0141037100762368
Chapter II Neoplasms,Leiomyoma of uterus,EPHB4,Ephrin type-B receptor 4,27119,604,1.36 [1.02-1.81],0.0376325889537951
Chapter II Neoplasms,Leiomyoma of uterus,EPO,Erythropoietin,26749,595,1.26 [1.17-1.35],2.0995269533853382e-10
Chapter II Neoplasms,Leiomyoma of uterus,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,26965,596,0.65 [0.51-0.84],0.000733841235702
Chapter II Neoplasms,Leiomyoma of uterus,ERBB3,Receptor tyrosine-protein kinase erbB-3,26709,588,0.58 [0.39-0.86],0.0061614528387763
Chapter II Neoplasms,Leiomyoma of uterus,ERCC1,DNA excision repair protein ERCC-1,22508,482,1.29 [1.04-1.61],0.0217141529203811
Chapter II Neoplasms,Leiomyoma of uterus,ESAM,Endothelial cell-selective adhesion molecule,27119,604,0.77 [0.61-0.97],0.0288424844215184
Chapter II Neoplasms,Leiomyoma of uterus,EXTL1,Exostosin-like 1,22605,487,0.79 [0.65-0.97],0.0261843611366833
Chapter II Neoplasms,Leiomyoma of uterus,EZR,Ezrin,27016,598,0.71 [0.53-0.97],0.0305936103176056
Chapter II Neoplasms,Leiomyoma of uterus,F10,Coagulation factor X,23354,511,0.70 [0.50-0.97],0.0324759406819632
Chapter II Neoplasms,Leiomyoma of uterus,F3,Tissue factor,26855,591,0.60 [0.46-0.78],0.0001200989243051
Chapter II Neoplasms,Leiomyoma of uterus,F7,Coagulation factor VII,26836,601,0.74 [0.59-0.94],0.0136935918625929
Chapter II Neoplasms,Leiomyoma of uterus,F9,Coagulation factor IX,26830,600,0.43 [0.29-0.63],1.1816320188189462e-05
Chapter II Neoplasms,Leiomyoma of uterus,FABP1,"Fatty acid-binding protein, liver",26790,588,0.90 [0.83-0.98],0.0100852382722419
Chapter II Neoplasms,Leiomyoma of uterus,FABP2,"Fatty acid-binding protein, intestinal",26791,593,0.89 [0.81-0.98],0.014177719340404
Chapter II Neoplasms,Leiomyoma of uterus,FABP4,"Fatty acid-binding protein, adipocyte",27119,604,0.76 [0.66-0.88],0.000338922706104
Chapter II Neoplasms,Leiomyoma of uterus,FAS,Tumor necrosis factor receptor superfamily member 6,27030,603,0.58 [0.45-0.76],8.540705792667846e-05
Chapter II Neoplasms,Leiomyoma of uterus,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,23302,509,1.43 [1.01-2.02],0.0417944764264303
Chapter II Neoplasms,Leiomyoma of uterus,FCER2,Low affinity immunoglobulin epsilon Fc receptor,26793,591,0.81 [0.70-0.95],0.0093339588754029
Chapter II Neoplasms,Leiomyoma of uterus,FCN2,Ficolin-2,26659,596,0.81 [0.70-0.95],0.0085618248493733
Chapter II Neoplasms,Leiomyoma of uterus,FGA,Fibrinogen alpha chain,22813,497,0.69 [0.52-0.92],0.0108703023764678
Chapter II Neoplasms,Leiomyoma of uterus,FGF12,Fibroblast growth factor 12,22684,489,0.75 [0.59-0.96],0.0246696524303263
Chapter II Neoplasms,Leiomyoma of uterus,FGF20,Fibroblast growth factor 20,22684,489,0.77 [0.61-0.97],0.0245386001462663
Chapter II Neoplasms,Leiomyoma of uterus,FGF23,Fibroblast growth factor 23,26970,597,1.45 [1.34-1.56],4.6700375743158275e-22
Chapter II Neoplasms,Leiomyoma of uterus,FGF5,Fibroblast growth factor 5,26247,581,0.76 [0.60-0.95],0.018229309826936
Chapter II Neoplasms,Leiomyoma of uterus,FGFR2,Fibroblast growth factor receptor 2,26893,593,0.67 [0.48-0.94],0.0206558644089446
Chapter II Neoplasms,Leiomyoma of uterus,FGL1,Fibrinogen-like protein 1,23354,511,0.88 [0.77-1.00],0.0482531183486614
Chapter II Neoplasms,Leiomyoma of uterus,FH,"Fumarate hydratase, mitochondrial",22591,487,1.10 [1.01-1.20],0.0381153797203829
Chapter II Neoplasms,Leiomyoma of uterus,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,26606,585,1.30 [1.01-1.69],0.0430200263660806
Chapter II Neoplasms,Leiomyoma of uterus,FLT3LG,Fms-related tyrosine kinase 3 ligand,27067,598,0.65 [0.53-0.81],0.0001396357665964
Chapter II Neoplasms,Leiomyoma of uterus,FOS,Proto-oncogene c-Fos,22466,480,1.34 [1.05-1.71],0.0187779115623518
Chapter II Neoplasms,Leiomyoma of uterus,FSHB,Follitropin subunit beta,22743,496,0.55 [0.49-0.63],1.8985084804734248e-19
Chapter II Neoplasms,Leiomyoma of uterus,FST,Follistatin,26874,594,0.83 [0.72-0.96],0.0106253791148107
Chapter II Neoplasms,Leiomyoma of uterus,FSTL1,Follistatin-related protein 1,22743,496,1.50 [1.03-2.17],0.0333674693731379
Chapter II Neoplasms,Leiomyoma of uterus,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",22865,498,1.13 [1.00-1.27],0.0483229991792614
Chapter II Neoplasms,Leiomyoma of uterus,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,27016,598,0.85 [0.73-1.00],0.0455032407175507
Chapter II Neoplasms,Leiomyoma of uterus,GART,Trifunctional purine biosynthetic protein adenosine-3,23302,509,0.61 [0.43-0.88],0.0081850021626772
Chapter II Neoplasms,Leiomyoma of uterus,GC,Vitamin D-binding protein,23380,507,0.66 [0.47-0.91],0.0129708370696495
Chapter II Neoplasms,Leiomyoma of uterus,GCG,Pro-glucagon,26159,574,1.06 [1.00-1.13],0.0438321618586923
Chapter II Neoplasms,Leiomyoma of uterus,GFRAL,GDNF family receptor alpha-like,22573,490,0.82 [0.71-0.94],0.0060627871244412
Chapter II Neoplasms,Leiomyoma of uterus,GIGYF2,GRB10-interacting GYF protein 2,23302,509,0.89 [0.79-0.99],0.0319930387422892
Chapter II Neoplasms,Leiomyoma of uterus,GLRX,Glutaredoxin-1,26620,591,0.86 [0.75-0.97],0.0162935461435547
Chapter II Neoplasms,Leiomyoma of uterus,GNPDA1,Glucosamine-6-phosphate isomerase 1,22743,496,0.70 [0.52-0.95],0.0213728108491269
Chapter II Neoplasms,Leiomyoma of uterus,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,25954,577,1.18 [1.10-1.28],2.089627710766372e-05
Chapter II Neoplasms,Leiomyoma of uterus,GPA33,Cell surface A33 antigen,26676,589,0.93 [0.88-0.98],0.007554933260237
Chapter II Neoplasms,Leiomyoma of uterus,GSR,"Glutathione reductase, mitochondrial",23212,505,0.52 [0.38-0.70],2.897974240832737e-05
Chapter II Neoplasms,Leiomyoma of uterus,GUSB,Beta-glucuronidase,26910,599,0.85 [0.76-0.97],0.0119897358365635
Chapter II Neoplasms,Leiomyoma of uterus,HAO1,Hydroxyacid oxidase 1,27012,597,0.94 [0.89-0.99],0.0210215771794575
Chapter II Neoplasms,Leiomyoma of uterus,HAVCR1,Hepatitis A virus cellular receptor 1,26975,597,0.86 [0.76-0.98],0.0199754248451271
Chapter II Neoplasms,Leiomyoma of uterus,HBZ,Hemoglobin subunit zeta,23347,511,0.92 [0.85-0.99],0.0323521593170893
Chapter II Neoplasms,Leiomyoma of uterus,HDDC2,5'-deoxynucleotidase HDDC2,23220,507,0.76 [0.63-0.93],0.0077573038760189
Chapter II Neoplasms,Leiomyoma of uterus,HEBP1,Heme-binding protein 1,26286,584,1.14 [1.02-1.28],0.0265803869252089
Chapter II Neoplasms,Leiomyoma of uterus,HEG1,Protein HEG homolog 1,22843,501,0.61 [0.45-0.85],0.0030306671495304
Chapter II Neoplasms,Leiomyoma of uterus,HEPACAM2,HEPACAM family member 2,23285,505,1.29 [1.05-1.58],0.0149519364564849
Chapter II Neoplasms,Leiomyoma of uterus,HEPH,Hephaestin,23347,511,2.51 [1.81-3.48],3.3639195100665724e-08
Chapter II Neoplasms,Leiomyoma of uterus,HMBS,Porphobilinogen deaminase,27012,597,0.83 [0.71-0.97],0.0156620322627426
Chapter II Neoplasms,Leiomyoma of uterus,HMOX1,Heme oxygenase 1,26482,586,0.75 [0.64-0.88],0.000480329798144
Chapter II Neoplasms,Leiomyoma of uterus,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,22743,496,1.24 [1.01-1.53],0.0390654958640093
Chapter II Neoplasms,Leiomyoma of uterus,HSPA1A,Heat shock 70 kDa protein 1A,26883,598,0.90 [0.82-1.00],0.0470667907941247
Chapter II Neoplasms,Leiomyoma of uterus,HYAL1,Hyaluronidase-1,26614,591,0.63 [0.46-0.87],0.0047295792682994
Chapter II Neoplasms,Leiomyoma of uterus,HYOU1,Hypoxia up-regulated protein 1,27119,604,0.59 [0.43-0.83],0.0020655162430076
Chapter II Neoplasms,Leiomyoma of uterus,ICAM1,Intercellular adhesion molecule 1,26658,598,0.64 [0.50-0.83],0.0008608985309891
Chapter II Neoplasms,Leiomyoma of uterus,IFNLR1,Interferon lambda receptor 1,26749,595,0.75 [0.61-0.92],0.0070267392870009
Chapter II Neoplasms,Leiomyoma of uterus,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,23332,508,1.48 [1.07-2.05],0.0173343722330946
Chapter II Neoplasms,Leiomyoma of uterus,IL12RB1,Interleukin-12 receptor subunit beta-1,26247,581,0.79 [0.65-0.97],0.023506371259817
Chapter II Neoplasms,Leiomyoma of uterus,IL18,Interleukin-18,26707,586,0.83 [0.71-0.97],0.0183096230334003
Chapter II Neoplasms,Leiomyoma of uterus,IL1B,Interleukin-1 beta,26120,577,0.84 [0.73-0.96],0.0134502443896915
Chapter II Neoplasms,Leiomyoma of uterus,IL1R2,Interleukin-1 receptor type 2,26748,588,0.67 [0.47-0.95],0.0245277653113243
Chapter II Neoplasms,Leiomyoma of uterus,IL1RAP,Interleukin-1 receptor accessory protein,26793,591,0.81 [0.68-0.96],0.0147793947728039
Chapter II Neoplasms,Leiomyoma of uterus,IL1RL2,Interleukin-1 receptor-like 2,26247,581,0.83 [0.70-0.99],0.0426841628562746
Chapter II Neoplasms,Leiomyoma of uterus,IL31RA,Interleukin-31 receptor subunit alpha,22590,488,0.58 [0.47-0.73],1.6798082457584004e-06
Chapter II Neoplasms,Leiomyoma of uterus,IL32,Interleukin-32,26749,595,0.75 [0.63-0.90],0.0015872414001177
Chapter II Neoplasms,Leiomyoma of uterus,IL36A,Interleukin-36 alpha,22684,489,1.14 [1.00-1.29],0.0425340124035207
Chapter II Neoplasms,Leiomyoma of uterus,IL6ST,Interleukin-6 receptor subunit beta,26791,593,0.57 [0.38-0.87],0.0084169478486005
Chapter II Neoplasms,Leiomyoma of uterus,INPP1,Inositol polyphosphate 1-phosphatase,26676,589,0.87 [0.76-0.99],0.0387886529985656
Chapter II Neoplasms,Leiomyoma of uterus,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,25762,566,0.80 [0.65-0.97],0.0267381515640583
Chapter II Neoplasms,Leiomyoma of uterus,ITGA11,Integrin alpha-11,26749,595,0.73 [0.60-0.90],0.0034299704695058
Chapter II Neoplasms,Leiomyoma of uterus,ITGA2,Integrin alpha-2,22843,501,0.66 [0.51-0.85],0.0010928158624103
Chapter II Neoplasms,Leiomyoma of uterus,ITGAV,Integrin alpha-V,27012,597,0.57 [0.37-0.87],0.009683189045623
Chapter II Neoplasms,Leiomyoma of uterus,ITGB1,Integrin beta-1,26744,598,0.61 [0.44-0.86],0.0044381303132807
Chapter II Neoplasms,Leiomyoma of uterus,ITGB5,Integrin beta-5,26893,593,0.78 [0.64-0.95],0.0143436004598445
Chapter II Neoplasms,Leiomyoma of uterus,JAM2,Junctional adhesion molecule B,27016,598,0.66 [0.49-0.88],0.0048628567382046
Chapter II Neoplasms,Leiomyoma of uterus,KDR,Vascular endothelial growth factor receptor 2,26893,593,0.69 [0.53-0.90],0.0054926839602692
Chapter II Neoplasms,Leiomyoma of uterus,KEL,Kell blood group glycoprotein,26124,574,1.26 [1.03-1.55],0.0275382958755226
Chapter II Neoplasms,Leiomyoma of uterus,KIAA0319,Dyslexia-associated protein KIAA0319,23285,505,0.67 [0.51-0.90],0.007170272849861
Chapter II Neoplasms,Leiomyoma of uterus,KIF20B,Kinesin-like protein KIF20B,22591,487,1.11 [1.01-1.23],0.0366034244981893
Chapter II Neoplasms,Leiomyoma of uterus,KLK4,Kallikrein-4,27012,597,1.54 [1.39-1.70],3.747222458067005e-17
Chapter II Neoplasms,Leiomyoma of uterus,KLKB1,Plasma kallikrein,22907,494,0.69 [0.50-0.96],0.0288701396053514
Chapter II Neoplasms,Leiomyoma of uterus,KRT18,"Keratin, type I cytoskeletal 18",26676,589,0.88 [0.80-0.97],0.0102760908015603
Chapter II Neoplasms,Leiomyoma of uterus,KRT19,"Keratin, type I cytoskeletal 19",26708,595,0.89 [0.80-1.00],0.0484165219433173
Chapter II Neoplasms,Leiomyoma of uterus,KYNU,Kynureninase,27067,598,0.80 [0.68-0.94],0.0058666055246307
Chapter II Neoplasms,Leiomyoma of uterus,LCAT,Phosphatidylcholine-sterol acyltransferase,23354,511,0.60 [0.43-0.84],0.0028041224914757
Chapter II Neoplasms,Leiomyoma of uterus,LEFTY2,Left-right determination factor 2,26968,594,2.37 [2.12-2.65],3.700850151833313e-51
Chapter II Neoplasms,Leiomyoma of uterus,LEP,Leptin,26791,593,0.89 [0.80-1.00],0.0486049340105579
Chapter II Neoplasms,Leiomyoma of uterus,LEPR,Leptin receptor,26791,593,0.73 [0.57-0.93],0.0118168088895232
Chapter II Neoplasms,Leiomyoma of uterus,LGALS3,Galectin-3,26849,598,0.71 [0.56-0.90],0.0047847114817498
Chapter II Neoplasms,Leiomyoma of uterus,LGALS4,Galectin-4,26790,588,0.78 [0.67-0.90],0.0005827990631191
Chapter II Neoplasms,Leiomyoma of uterus,LHB,Lutropin subunit beta,26159,574,0.86 [0.78-0.95],0.0022468774662961
Chapter II Neoplasms,Leiomyoma of uterus,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,26838,598,0.88 [0.78-0.99],0.0383835279233997
Chapter II Neoplasms,Leiomyoma of uterus,LIF,Leukemia inhibitory factor,26124,574,1.15 [1.02-1.31],0.0251235762030425
Chapter II Neoplasms,Leiomyoma of uterus,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,26746,592,0.74 [0.59-0.93],0.0086597112180463
Chapter II Neoplasms,Leiomyoma of uterus,LMOD1,Leiomodin-1,23302,509,1.46 [1.22-1.75],4.982923150109211e-05
Chapter II Neoplasms,Leiomyoma of uterus,LPL,Lipoprotein lipase,26791,593,0.83 [0.72-0.97],0.0154915182170268
Chapter II Neoplasms,Leiomyoma of uterus,LRP1,Prolow-density lipoprotein receptor-related protein 1,26676,589,1.34 [1.03-1.75],0.0301252467082557
Chapter II Neoplasms,Leiomyoma of uterus,LTBP2,Latent-transforming growth factor beta-binding protein 2,27119,604,1.61 [1.29-2.00],2.000388240565888e-05
Chapter II Neoplasms,Leiomyoma of uterus,LUZP2,Leucine zipper protein 2,23218,506,1.23 [1.04-1.45],0.0137872474908687
Chapter II Neoplasms,Leiomyoma of uterus,LYAR,Cell growth-regulating nucleolar protein,26159,574,0.85 [0.73-0.99],0.0427849494725788
Chapter II Neoplasms,Leiomyoma of uterus,MAEA,E3 ubiquitin-protein transferase MAEA,26159,574,0.80 [0.65-0.98],0.0275921370193249
Chapter II Neoplasms,Leiomyoma of uterus,MATN2,Matrilin-2,26837,589,1.64 [1.29-2.09],4.836988494907575e-05
Chapter II Neoplasms,Leiomyoma of uterus,MATN3,Matrilin-3,26566,583,1.46 [1.17-1.82],0.0007698451932432
Chapter II Neoplasms,Leiomyoma of uterus,MCAM,Cell surface glycoprotein MUC18,26878,601,0.79 [0.64-0.97],0.0271193162494067
Chapter II Neoplasms,Leiomyoma of uterus,MDK,Midkine,26816,589,1.24 [1.09-1.41],0.0011027463220287
Chapter II Neoplasms,Leiomyoma of uterus,MEGF9,Multiple epidermal growth factor-like domains protein 9,27030,603,0.51 [0.37-0.72],0.0001237083842075
Chapter II Neoplasms,Leiomyoma of uterus,MELTF,Melanotransferrin,23347,511,1.34 [1.01-1.78],0.0408697447766782
Chapter II Neoplasms,Leiomyoma of uterus,MEP1A,Meprin A subunit alpha,23220,507,0.88 [0.78-1.00],0.0446422570990972
Chapter II Neoplasms,Leiomyoma of uterus,MET,Hepatocyte growth factor receptor,26867,600,0.45 [0.31-0.64],9.054689116888991e-06
Chapter II Neoplasms,Leiomyoma of uterus,MFAP4,Microfibril-associated glycoprotein 4,22843,501,1.31 [1.00-1.71],0.0499969043665516
Chapter II Neoplasms,Leiomyoma of uterus,MFAP5,Microfibrillar-associated protein 5,27119,604,1.60 [1.35-1.91],7.287463393346911e-08
Chapter II Neoplasms,Leiomyoma of uterus,MME,Neprilysin,26676,589,0.89 [0.81-0.98],0.018420518833721
Chapter II Neoplasms,Leiomyoma of uterus,MMP10,Stromelysin-2,26749,584,1.38 [1.24-1.54],2.2187959746036434e-09
Chapter II Neoplasms,Leiomyoma of uterus,MRC1,Macrophage mannose receptor 1,23354,511,0.68 [0.51-0.91],0.0106418607183087
Chapter II Neoplasms,Leiomyoma of uterus,MSLNL,Mesothelin-like protein,22685,498,0.72 [0.57-0.93],0.010412072309594
Chapter II Neoplasms,Leiomyoma of uterus,MUC16,Mucin-16,26676,589,1.09 [1.04-1.14],7.914874038354482e-05
Chapter II Neoplasms,Leiomyoma of uterus,MYH4,Myosin-4,22605,487,1.31 [1.14-1.51],0.0001240837303914
Chapter II Neoplasms,Leiomyoma of uterus,MYOC,Myocilin,26793,591,0.85 [0.73-1.00],0.0464591219807026
Chapter II Neoplasms,Leiomyoma of uterus,NBL1,Neuroblastoma suppressor of tumorigenicity 1,26893,593,2.00 [1.53-2.62],3.929269993839905e-07
Chapter II Neoplasms,Leiomyoma of uterus,NCS1,Neuronal calcium sensor 1,27012,597,1.55 [1.21-1.99],0.0005131819629647
Chapter II Neoplasms,Leiomyoma of uterus,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,23218,506,1.19 [1.08-1.32],0.0006749285933943
Chapter II Neoplasms,Leiomyoma of uterus,NECTIN2,Nectin-2,26746,592,0.76 [0.59-0.99],0.0398529498641802
Chapter II Neoplasms,Leiomyoma of uterus,NELL1,Protein kinase C-binding protein NELL1,26893,593,0.81 [0.68-0.96],0.0168496434191344
Chapter II Neoplasms,Leiomyoma of uterus,NFIC,Nuclear factor 1 C-type,23302,509,1.20 [1.04-1.40],0.0158218626099481
Chapter II Neoplasms,Leiomyoma of uterus,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,26606,585,0.89 [0.80-0.99],0.0392665377831303
Chapter II Neoplasms,Leiomyoma of uterus,NOMO1,Nodal modulator 1,26793,591,0.62 [0.45-0.84],0.0019324610189604
Chapter II Neoplasms,Leiomyoma of uterus,NOS3,"Nitric oxide synthase, endothelial",26124,574,1.22 [1.08-1.37],0.0012573174465747
Chapter II Neoplasms,Leiomyoma of uterus,NOTCH1,Neurogenic locus notch homolog protein 1,27119,604,0.62 [0.39-0.99],0.0457209518099016
Chapter II Neoplasms,Leiomyoma of uterus,NOTCH3,Neurogenic locus notch homolog protein 3,27119,604,1.27 [1.04-1.55],0.02011405081015
Chapter II Neoplasms,Leiomyoma of uterus,NPHS1,Nephrin,22684,489,0.65 [0.49-0.85],0.0018486478385364
Chapter II Neoplasms,Leiomyoma of uterus,NPTX1,Neuronal pentraxin-1,26793,591,0.82 [0.68-0.99],0.0419677584247052
Chapter II Neoplasms,Leiomyoma of uterus,NRP2,Neuropilin-2,26793,591,1.35 [1.06-1.72],0.0136419859046614
Chapter II Neoplasms,Leiomyoma of uterus,NRXN3,Neurexin-3,22685,498,0.74 [0.56-0.98],0.0350232108901028
Chapter II Neoplasms,Leiomyoma of uterus,NT5C1A,Cytosolic 5'-nucleotidase 1A,23285,505,1.42 [1.15-1.75],0.0011669816461205
Chapter II Neoplasms,Leiomyoma of uterus,NTF3,Neurotrophin-3,26749,595,0.75 [0.61-0.93],0.0081911123613263
Chapter II Neoplasms,Leiomyoma of uterus,NTF4,Neurotrophin-4,26159,574,1.25 [1.09-1.43],0.0017844581437191
Chapter II Neoplasms,Leiomyoma of uterus,NTRK2,BDNF/NT-3 growth factors receptor,26791,593,0.64 [0.48-0.84],0.0016591429610607
Chapter II Neoplasms,Leiomyoma of uterus,NTproBNP,N-terminal prohormone of brain natriuretic peptide,26791,593,1.10 [1.02-1.18],0.0141644506850966
Chapter II Neoplasms,Leiomyoma of uterus,OBP2B,Odorant-binding protein 2b,26525,583,1.25 [1.12-1.39],5.912855863776876e-05
Chapter II Neoplasms,Leiomyoma of uterus,OCLN,Occludin,23302,509,0.80 [0.65-0.97],0.026780404463608
Chapter II Neoplasms,Leiomyoma of uterus,ODAM,Odontogenic ameloblast-associated protein,26083,573,0.83 [0.72-0.97],0.0194883116581569
Chapter II Neoplasms,Leiomyoma of uterus,OGFR,Opioid growth factor receptor,26676,589,0.79 [0.63-0.98],0.0361818876240444
Chapter II Neoplasms,Leiomyoma of uterus,OGN,Mimecan,26793,591,1.63 [1.37-1.94],3.9009778669752484e-08
Chapter II Neoplasms,Leiomyoma of uterus,OLFM4,Olfactomedin-4,21983,478,0.90 [0.84-0.97],0.0049533257602556
Chapter II Neoplasms,Leiomyoma of uterus,OSM,Oncostatin-M,26622,593,0.91 [0.82-1.00],0.0473260419742301
Chapter II Neoplasms,Leiomyoma of uterus,OSMR,Oncostatin-M-specific receptor subunit beta,26925,601,0.61 [0.43-0.85],0.0040860519348579
Chapter II Neoplasms,Leiomyoma of uterus,PAEP,Glycodelin,26606,585,1.31 [1.25-1.37],6.205847784103554e-31
Chapter II Neoplasms,Leiomyoma of uterus,PAMR1,Inactive serine protease PAMR1,26793,591,0.77 [0.60-0.99],0.0436214960738057
Chapter II Neoplasms,Leiomyoma of uterus,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,22799,499,0.81 [0.67-0.98],0.0345634911647323
Chapter II Neoplasms,Leiomyoma of uterus,PCDH9,Protocadherin-9,23220,507,0.72 [0.57-0.91],0.006559988723263
Chapter II Neoplasms,Leiomyoma of uterus,PCSK9,Proprotein convertase subtilisin/kexin type 9,27119,604,0.69 [0.57-0.82],4.407206066308939e-05
Chapter II Neoplasms,Leiomyoma of uterus,PDCD1,Programmed cell death protein 1,26971,597,0.78 [0.66-0.93],0.0062149882109166
Chapter II Neoplasms,Leiomyoma of uterus,PECAM1,Platelet endothelial cell adhesion molecule,26793,591,0.75 [0.59-0.96],0.0217303230761536
Chapter II Neoplasms,Leiomyoma of uterus,PENK,Proenkephalin-A,22843,501,1.42 [1.10-1.84],0.0076633908213332
Chapter II Neoplasms,Leiomyoma of uterus,PEPD,Xaa-Pro dipeptidase,23354,511,0.62 [0.45-0.85],0.0033618739434151
Chapter II Neoplasms,Leiomyoma of uterus,PGA4,Pepsin A-4,23354,511,1.15 [1.01-1.32],0.0305045020694082
Chapter II Neoplasms,Leiomyoma of uterus,PI16,Peptidase inhibitor 16,23354,511,0.55 [0.39-0.77],0.0005315582690489
Chapter II Neoplasms,Leiomyoma of uterus,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,26749,595,0.78 [0.69-0.88],4.862421212963647e-05
Chapter II Neoplasms,Leiomyoma of uterus,PLA2G2A,"Phospholipase A2, membrane associated",26709,597,0.87 [0.76-0.99],0.030618085634236
Chapter II Neoplasms,Leiomyoma of uterus,PLG,Plasminogen,22765,494,0.66 [0.45-0.96],0.0320133610353004
Chapter II Neoplasms,Leiomyoma of uterus,PLIN3,Perilipin-3,26791,593,0.82 [0.69-0.97],0.0223120371835349
Chapter II Neoplasms,Leiomyoma of uterus,PLXNB2,Plexin-B2,26989,603,0.68 [0.50-0.93],0.0155189603133201
Chapter II Neoplasms,Leiomyoma of uterus,POSTN,Periostin,23332,508,1.38 [1.11-1.71],0.0030854195613363
Chapter II Neoplasms,Leiomyoma of uterus,PRCP,Lysosomal Pro-X carboxypeptidase,26952,598,0.65 [0.52-0.83],0.0003475467208222
Chapter II Neoplasms,Leiomyoma of uterus,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,26247,581,0.85 [0.74-0.98],0.0245756083666817
Chapter II Neoplasms,Leiomyoma of uterus,PRL,Prolactin,27016,598,1.22 [1.13-1.33],2.7896737879171288e-06
Chapter II Neoplasms,Leiomyoma of uterus,PRND,Prion-like protein doppel,23285,505,1.62 [1.41-1.87],1.2870818434881176e-11
Chapter II Neoplasms,Leiomyoma of uterus,PROC,Vitamin K-dependent protein C,26830,600,0.47 [0.36-0.62],1.1174226754164052e-07
Chapter II Neoplasms,Leiomyoma of uterus,PROK1,Prokineticin-1,26749,595,1.26 [1.16-1.37],1.743420317047091e-07
Chapter II Neoplasms,Leiomyoma of uterus,PROS1,Vitamin K-dependent protein S,23380,507,0.65 [0.46-0.93],0.0166187765617295
Chapter II Neoplasms,Leiomyoma of uterus,PRSS8,Prostasin,26700,594,0.82 [0.69-0.99],0.0344699136781811
Chapter II Neoplasms,Leiomyoma of uterus,PTK7,Inactive tyrosine-protein kinase 7,26124,574,1.98 [1.71-2.30],3.1305145631201426e-19
Chapter II Neoplasms,Leiomyoma of uterus,PTN,Pleiotrophin,26286,584,1.54 [1.35-1.77],4.572040499035905e-10
Chapter II Neoplasms,Leiomyoma of uterus,PTPRF,Receptor-type tyrosine-protein phosphatase F,27119,604,0.60 [0.47-0.76],3.724409076447216e-05
Chapter II Neoplasms,Leiomyoma of uterus,PTPRM,Receptor-type tyrosine-protein phosphatase mu,26707,593,0.61 [0.45-0.81],0.0008581651763617
Chapter II Neoplasms,Leiomyoma of uterus,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,23347,511,0.69 [0.53-0.89],0.0049497604578156
Chapter II Neoplasms,Leiomyoma of uterus,PZP,Pregnancy zone protein,23380,507,0.86 [0.76-0.98],0.022243671057886
Chapter II Neoplasms,Leiomyoma of uterus,QDPR,Dihydropteridine reductase,26665,592,0.85 [0.72-1.00],0.0490321970565916
Chapter II Neoplasms,Leiomyoma of uterus,RBKS,Ribokinase,26169,577,0.86 [0.75-0.99],0.0372514111062157
Chapter II Neoplasms,Leiomyoma of uterus,RBP5,Retinol-binding protein 5,26676,589,0.82 [0.72-0.94],0.0047886087796355
Chapter II Neoplasms,Leiomyoma of uterus,RCOR1,REST corepressor 1,26286,584,0.80 [0.65-0.97],0.0255191855107095
Chapter II Neoplasms,Leiomyoma of uterus,REN,Renin,26791,593,1.15 [1.04-1.27],0.0080922489004246
Chapter II Neoplasms,Leiomyoma of uterus,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,26676,589,0.81 [0.68-0.96],0.0146676469695443
Chapter II Neoplasms,Leiomyoma of uterus,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,22605,487,0.85 [0.74-0.98],0.0264898696044082
Chapter II Neoplasms,Leiomyoma of uterus,RLN1,Prorelaxin H1,23302,509,1.12 [1.04-1.20],0.0020108286067505
Chapter II Neoplasms,Leiomyoma of uterus,RLN2,Prorelaxin H2,22803,498,1.09 [1.05-1.13],3.887055279686927e-05
Chapter II Neoplasms,Leiomyoma of uterus,RNASE10,Inactive ribonuclease-like protein 10,22743,496,1.18 [1.00-1.39],0.0455219027395236
Chapter II Neoplasms,Leiomyoma of uterus,RSPO1,R-spondin-1,26606,585,2.53 [2.17-2.94],1.5088110893318026e-32
Chapter II Neoplasms,Leiomyoma of uterus,RSPO3,R-spondin-3,27012,597,3.26 [2.65-4.01],6.527972404194184e-29
Chapter II Neoplasms,Leiomyoma of uterus,S100A12,Protein S100-A12,26431,586,0.91 [0.82-1.00],0.0447018928091756
Chapter II Neoplasms,Leiomyoma of uterus,S100G,Protein S100-G,23302,509,1.38 [1.17-1.64],0.0001525815535497
Chapter II Neoplasms,Leiomyoma of uterus,SCARA5,Scavenger receptor class A member 5,27016,598,0.78 [0.61-0.99],0.0444618206130166
Chapter II Neoplasms,Leiomyoma of uterus,SCGB3A1,Secretoglobin family 3A member 1,22843,501,0.67 [0.47-0.95],0.0235565055968953
Chapter II Neoplasms,Leiomyoma of uterus,SCGN,Secretagogin,26247,581,0.77 [0.65-0.92],0.003679468043783
Chapter II Neoplasms,Leiomyoma of uterus,SCN4B,Sodium channel subunit beta-4,22743,496,0.80 [0.65-0.98],0.0332168864771316
Chapter II Neoplasms,Leiomyoma of uterus,SCRN1,Secernin-1,26749,595,0.87 [0.76-0.99],0.0295836056356819
Chapter II Neoplasms,Leiomyoma of uterus,SDC1,Syndecan-1,26791,593,0.82 [0.67-0.99],0.0345334035986788
Chapter II Neoplasms,Leiomyoma of uterus,SDK2,Protein sidekick-2,22843,501,1.33 [1.09-1.64],0.006000844520026
Chapter II Neoplasms,Leiomyoma of uterus,SELE,E-selectin,27119,604,0.86 [0.74-0.98],0.0288408121885327
Chapter II Neoplasms,Leiomyoma of uterus,SELPLG,P-selectin glycoprotein ligand 1,26749,595,0.79 [0.64-0.97],0.0269704033990766
Chapter II Neoplasms,Leiomyoma of uterus,SEMA3F,Semaphorin-3F,26791,593,0.68 [0.52-0.91],0.0081101510828882
Chapter II Neoplasms,Leiomyoma of uterus,SERPINA3,Alpha-1-antichymotrypsin,23280,504,0.38 [0.21-0.69],0.0016660519291471
Chapter II Neoplasms,Leiomyoma of uterus,SERPINA9,Serpin A9,26538,588,0.84 [0.76-0.93],0.0004623512313869
Chapter II Neoplasms,Leiomyoma of uterus,SERPINC1,Antithrombin-III,23329,506,0.45 [0.26-0.80],0.00603981194919
Chapter II Neoplasms,Leiomyoma of uterus,SERPING1,Plasma protease C1 inhibitor,23329,506,0.59 [0.38-0.93],0.021343206416343
Chapter II Neoplasms,Leiomyoma of uterus,SEZ6L2,Seizure 6-like protein 2,26676,589,4.75 [3.74-6.04],3.970812217066656e-37
Chapter II Neoplasms,Leiomyoma of uterus,SFRP1,Secreted frizzled-related protein 1,26526,583,1.94 [1.70-2.23],1.5313163348646157e-21
Chapter II Neoplasms,Leiomyoma of uterus,SFRP4,Secreted frizzled-related protein 4,22843,501,1.75 [1.44-2.14],2.9659385837612463e-08
Chapter II Neoplasms,Leiomyoma of uterus,SFTPD,Pulmonary surfactant-associated protein D,26791,593,0.89 [0.80-1.00],0.0414648808646597
Chapter II Neoplasms,Leiomyoma of uterus,SIGLEC7,Sialic acid-binding Ig-like lectin 7,26791,593,0.75 [0.58-0.97],0.0275818046631869
Chapter II Neoplasms,Leiomyoma of uterus,SIGLEC8,Sialic acid-binding Ig-like lectin 8,22743,496,0.79 [0.66-0.96],0.0157599932406124
Chapter II Neoplasms,Leiomyoma of uterus,SLAMF1,Signaling lymphocytic activation molecule,26247,581,0.85 [0.76-0.96],0.0092648204532451
Chapter II Neoplasms,Leiomyoma of uterus,SLC39A14,Zinc transporter ZIP14,26124,574,0.79 [0.62-1.00],0.0481847726545482
Chapter II Neoplasms,Leiomyoma of uterus,SLIT2,Slit homolog 2 protein,26124,574,1.18 [1.04-1.34],0.009424017232917
Chapter II Neoplasms,Leiomyoma of uterus,SLITRK1,SLIT and NTRK-like protein 1,22684,489,0.72 [0.55-0.94],0.0177314974356868
Chapter II Neoplasms,Leiomyoma of uterus,SMOC2,SPARC-related modular calcium-binding protein 2,26922,598,2.42 [2.08-2.82],1.776159183496686e-29
Chapter II Neoplasms,Leiomyoma of uterus,SORBS1,Sorbin and SH3 domain-containing protein 1,23302,509,1.22 [1.03-1.46],0.0237688914680235
Chapter II Neoplasms,Leiomyoma of uterus,SORD,Sorbitol dehydrogenase,26889,592,0.89 [0.80-0.99],0.026795764317335
Chapter II Neoplasms,Leiomyoma of uterus,SOST,Sclerostin,26746,592,0.78 [0.65-0.93],0.0070707318566123
Chapter II Neoplasms,Leiomyoma of uterus,SPARCL1,SPARC-like protein 1,26794,601,1.32 [1.03-1.70],0.0289173522817509
Chapter II Neoplasms,Leiomyoma of uterus,SPINK1,Serine protease inhibitor Kazal-type 1,26793,591,0.81 [0.68-0.97],0.0194915920020615
Chapter II Neoplasms,Leiomyoma of uterus,SPINK5,Serine protease inhibitor Kazal-type 5,26793,591,1.30 [1.05-1.62],0.0181277452361014
Chapter II Neoplasms,Leiomyoma of uterus,SPON1,Spondin-1,26837,589,1.46 [1.18-1.80],0.0004607203413178
Chapter II Neoplasms,Leiomyoma of uterus,SPON2,Spondin-2,26662,592,1.69 [1.38-2.07],5.663334859893259e-07
Chapter II Neoplasms,Leiomyoma of uterus,SRPX,Sushi repeat-containing protein SRPX,23347,511,1.55 [1.20-2.00],0.0006988478395658
Chapter II Neoplasms,Leiomyoma of uterus,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",27119,604,0.75 [0.58-0.96],0.0220489774246608
Chapter II Neoplasms,Leiomyoma of uterus,STC2,Stanniocalcin-2,26758,590,2.19 [1.67-2.87],1.288207077840576e-08
Chapter II Neoplasms,Leiomyoma of uterus,TAFA5,Chemokine-like protein TAFA-5,26676,589,1.48 [1.21-1.80],9.887295928595834e-05
Chapter II Neoplasms,Leiomyoma of uterus,TDO2,"Tryptophan 2,3-dioxygenase",22685,498,0.77 [0.59-0.99],0.0411552883296495
Chapter II Neoplasms,Leiomyoma of uterus,TEK,Angiopoietin-1 receptor,26893,593,0.67 [0.49-0.93],0.0152776969795762
Chapter II Neoplasms,Leiomyoma of uterus,TF,Serotransferrin,23380,507,1.78 [1.23-2.58],0.0023638135063921
Chapter II Neoplasms,Leiomyoma of uterus,TFPI,Tissue factor pathway inhibitor,26696,598,0.69 [0.54-0.87],0.0020024017666463
Chapter II Neoplasms,Leiomyoma of uterus,TFRC,Transferrin receptor protein 1,26885,601,1.60 [1.37-1.88],3.879913709488726e-09
Chapter II Neoplasms,Leiomyoma of uterus,THBD,Thrombomodulin,26791,593,0.62 [0.47-0.81],0.0005309020016443
Chapter II Neoplasms,Leiomyoma of uterus,THBS2,Thrombospondin-2,26793,591,1.51 [1.26-1.82],1.0235989659778687e-05
Chapter II Neoplasms,Leiomyoma of uterus,THBS4,Thrombospondin-4,26785,599,1.47 [1.26-1.72],1.5183424781672867e-06
Chapter II Neoplasms,Leiomyoma of uterus,THOP1,Thimet oligopeptidase,26665,590,0.65 [0.51-0.82],0.0004416297239654
Chapter II Neoplasms,Leiomyoma of uterus,THPO,Thrombopoietin,26286,584,0.76 [0.63-0.93],0.006070709252919
Chapter II Neoplasms,Leiomyoma of uterus,THY1,Thy-1 membrane glycoprotein,27016,598,1.38 [1.07-1.79],0.0137937729905109
Chapter II Neoplasms,Leiomyoma of uterus,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,26878,601,0.84 [0.71-0.99],0.0379169264685039
Chapter II Neoplasms,Leiomyoma of uterus,TIMP2,Metalloproteinase inhibitor 2,23347,511,1.50 [1.20-1.87],0.0003117564839629
Chapter II Neoplasms,Leiomyoma of uterus,TIMP4,Metalloproteinase inhibitor 4,26793,591,0.72 [0.60-0.87],0.0005795098205023
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,26606,585,0.69 [0.53-0.89],0.0047569487612168
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,26790,588,0.67 [0.52-0.85],0.0013562890031701
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,26247,581,0.82 [0.69-0.99],0.0343479434941719
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,22843,501,0.70 [0.56-0.87],0.0011567961958443
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,27016,598,0.76 [0.58-1.00],0.0471187193616617
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,26606,585,0.85 [0.74-0.98],0.0209100173347052
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,27016,598,0.77 [0.65-0.91],0.0019060754699245
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,26606,585,0.80 [0.66-0.98],0.0270872199135949
Chapter II Neoplasms,Leiomyoma of uterus,TNFSF11,Tumor necrosis factor ligand superfamily member 11,26749,595,1.13 [1.01-1.27],0.0402018994948937
Chapter II Neoplasms,Leiomyoma of uterus,TNFSF13,Tumor necrosis factor ligand superfamily member 13,26922,598,1.42 [1.09-1.86],0.0100372100022787
Chapter II Neoplasms,Leiomyoma of uterus,TNNI3,"Troponin I, cardiac muscle",26286,584,1.14 [1.04-1.26],0.0057486553516886
Chapter II Neoplasms,Leiomyoma of uterus,TOP1MT,"DNA topoisomerase I, mitochondrial",22508,482,1.16 [1.00-1.35],0.046709965616609
Chapter II Neoplasms,Leiomyoma of uterus,TPK1,Thiamin pyrophosphokinase 1,23347,511,0.64 [0.48-0.86],0.0029310543759857
Chapter II Neoplasms,Leiomyoma of uterus,TSPAN1,Tetraspanin-1,26286,584,1.81 [1.60-2.04],1.5085542535345022e-21
Chapter II Neoplasms,Leiomyoma of uterus,TYRO3,Tyrosine-protein kinase receptor TYRO3,26791,593,0.74 [0.57-0.95],0.0192529864277109
Chapter II Neoplasms,Leiomyoma of uterus,UMOD,Uromodulin,27041,603,0.87 [0.76-0.99],0.0318970553587972
Chapter II Neoplasms,Leiomyoma of uterus,VASN,Vasorin,26360,587,0.76 [0.58-1.00],0.0470688461043944
Chapter II Neoplasms,Leiomyoma of uterus,VEGFD,Vascular endothelial growth factor D,27018,596,1.32 [1.07-1.63],0.0093436348186078
Chapter II Neoplasms,Leiomyoma of uterus,VNN1,Pantetheinase,23354,511,0.89 [0.80-0.99],0.0385118957023846
Chapter II Neoplasms,Leiomyoma of uterus,VTCN1,V-set domain-containing T-cell activation inhibitor 1,26159,574,1.58 [1.31-1.90],2.221041493058756e-06
Chapter II Neoplasms,Leiomyoma of uterus,VWA1,von Willebrand factor A domain-containing protein 1,26968,594,0.79 [0.66-0.94],0.0069971086434656
Chapter II Neoplasms,Leiomyoma of uterus,VWC2,Brorin,26518,582,1.85 [1.54-2.24],1.1224900796872364e-10
Chapter II Neoplasms,Leiomyoma of uterus,WFDC2,WAP four-disulfide core domain protein 2,25426,565,1.38 [1.13-1.67],0.0012306671767327
Chapter II Neoplasms,Leiomyoma of uterus,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",26529,582,1.38 [1.16-1.65],0.0002728451203305
